Reuters logo
Sweden approves generic copy of GSK's top lung drug
January 14, 2014 / 12:40 PM / in 4 years

Sweden approves generic copy of GSK's top lung drug

LONDON, Jan 14 (Reuters) - Sweden has followed Denmark and Germany in approving the sale of a generic copy of GlaxoSmithKline’s $8 billion-a-year inhaled lung drug Advair.

Britain’s Vectura said on Tuesday its partner Sandoz, the generics division of Switzerland’s Novartis , had received Swedish authorisation for its generic version of the drug, known as AirFluSal Forspiro.

The initial Danish green light was given to the product in December.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below